Beskrivning
Land | Norge |
---|---|
Lista | Euronext Growth Oslo |
Sektor | Hälsovård |
Industri | Bioteknik |
2022-08-24 15:36:29
OSLO, NORWAY - 24 August 2022. On 24 August 2022 Circa Group AS (the "Company")
have allocated share options in the Company to the following primary insiders in
accordance with the Company's Long Term Incentive (LTI) program:
Director Trond Stangeby 50,000 LTI options with strike price NOK 16.75
Director Greg Court 50,000 LTI options with strike price NOK 16.75
Director Martin Laudenbach 50,000 LTI options with strike price NOK 8.6032
Director Elise Fahlén 50,000 LTI options with strike price NOK 8.6032
Global Head of Production Philipp Morgenthaler 200,000 LTI options with strike
price NOK 7.4332
Group General Counsel Jens Even Højlund Pedersen 50,000 LTI options with strike
price NOK 7.4332
Please refer to the attached notifications of transactions for further details.
About Circa
Established in 2006, Circa Group converts non-food biomass into advanced
bio-based chemicals with its proprietary FuracellTM process. Its developing
product portfolio includes flavours, biopolymers, and bio-solvents including
CyreneTM, an alternative to traditional polar aprotic solvents, which is produced
in one step from platform biomolecule Levoglucosenone. By creating renewable
chemicals from cellulose, Circa is extracting value from non-food biomass and
addressing a gap in the market by providing bio-based alternatives contributing
to a more circular economy. In March 2021, Circa Group successfully listed on
the Euronext Growth Market in Oslo, stock symbol CIRCA.
www.circa-group.com
Investor Contact Circa Group
Tone Leivestad, Chief Financial Officer
Circa Group AS
tone.leivestad@circa-group.com
Tel: +47 406 39 455
Media Contact
Scott Engebrigtsen
Hill and Knowlton Strategies
Scott.Engebrigtsen@hkstrategies.com
Tel: +47 900 43 484